Teladoc Health, Inc. (TDOC) Price CAGR:9.81%(TTM)
Over the latest trailing 12-month period, Teladoc Health, Inc. (TDOC)'s price cagr is +9.81%. The comparable SPY value is +25.12%. Year-to-date price return is +7.52%. Price CAGR uses adjusted close price history and excludes dividends.
Over longer horizons, Teladoc Health, Inc.'s Price CAGR averages -31.80% over 3 years and -45.50% over 5 years. The price CAGR (Compound Annual Growth Rate) shows how Teladoc Health, Inc.'s stock price has grown over various time periods. This measures pure price appreciation without including dividends.
TDOC Price CAGR Chart
Teladoc Health, Inc. (TDOC)
TDOC Quarterly Price (YoY)
Price growth vs the same quarter one year earlier, last 20 quarters.
TDOC Price CAGR History
| Year | Start Price | End Price | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | 9.21 | 8.85 | -0.36 | -3.91% | -3.91% |
| 2024 | 24.55 | 9.21 | -15.34 | -62.48% | -62.48% |
| 2023 | 34.83 | 24.55 | -10.28 | -29.51% | -29.51% |
| 2022 | 164.64 | 34.83 | -129.81 | -78.84% | -78.84% |
| 2021 | 198.85 | 164.64 | -34.21 | -17.20% | -17.20% |
| 2020 | 66.92 | 198.85 | +131.93 | +197.15% | +197.15% |
| 2019 | 58.05 | 66.92 | +8.87 | +15.28% | +15.28% |
| 2018 | 35.25 | 58.05 | +22.80 | +64.68% | +64.68% |
| 2017 | 15.93 | 35.25 | +19.32 | +121.28% | +121.28% |
| 2016 | 19.00 | 15.93 | -3.07 | -16.16% | -16.16% |
Quarterly Price: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q2 2026 | 8 | +39.1% | -13.0% |
| Q1 2026 | 5 | -21.4% | -32.6% |
| Q4 2025 | 7 | -15.5% | -25.6% |
| Q3 2025 | 8 | -5.9% | -10.7% |
| Q2 2025 | 9 | +7.7% | -14.2% |
| Q1 2025 | 8 | -13.1% | -46.2% |
| Q4 2024 | 9 | +1.4% | -57.9% |
| Q3 2024 | 9 | -9.6% | -50.5% |
| Q2 2024 | 10 | -32.6% | -59.8% |
| Q1 2024 | 15 | -31.9% | -39.9% |
| Q4 2023 | 22 | +19.3% | -6.6% |
| Q3 2023 | 19 | -26.6% | -26.9% |
| Q2 2023 | 25 | +0.9% | -28.0% |
| Q1 2023 | 25 | +5.8% | -65.3% |
| Q4 2022 | 24 | -6.7% | -74.9% |
| Q3 2022 | 25 | -27.7% | -80.0% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Teladoc Health, Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Charles Divita